New Two-Pronged attack on breast cancer in the liver
NCT ID NCT06875128
Summary
This study is testing a two-step treatment for breast cancer that has mainly spread to the liver. Researchers want to see if a high-dose chemotherapy procedure that targets the liver directly, followed by standard cancer drugs, works better and is safer than using the standard drugs alone. The trial will involve about 90 participants whose cancer has progressed after other treatments.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC BREAST CANCER IN THE LIVER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Moffitt Cancer Center
RECRUITINGTampa, Florida, 33612, United States
-
Ohio State University, Stefanie Spielman Comprehensive Breast Center
RECRUITINGColumbus, Ohio, 43212, United States
Conditions
Explore the condition pages connected to this study.